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ABSTRACT  
Recent reports on emergence of multidrug resistant bacteria are cause of concern in medical world. Several ayurvedic drugs have been proved to 
contain the antimicrobial activity. Literature on effect of ayurvedic drugs on multidrug resistant bacterial pathogens is limited. Present study reports 
the antimicrobial effect of Achyranthes aspera (Apamarga) crude extracts  on the clinical isolates of  multidrug resistant bacteria. The drug  was 
evaluated by using phytochemical tests. Crude extracts of aqueous, methanol, ethanol and chloroform was prepared. Antibacterial activity against 
clinically isolated multidrug resistant bacteria belonging to groups of bacillus, citrobacter, E.coli, klebsiella, proteus and salmonella was tested. The 
drug showed highest efficacy against Bacillus organism while least effectiveness on Proteus spp bacteria. Results of the study conclude that the 
medicinal plant A. aspera might be useful against multidrug resistance in pathogens of clinical importance.  
Key words: Apamarga, Achyranthes aspera, anti-bacterial activity, multidrug resistant pathogens.  
 
INTRODUCTION 
Infectious diseases are still a major threat to public health, 
despite  the  tremendous  progress  in  human  medicine. 
Their impact is particularly large in developing countries 
like India, due to the relative unavailability of medicines 
and  the  emergence  of  widespread  drug  resistance. 
Research on new antimicrobial substances must therefore 
be  continued  and  all  possible  strategies  should  be 
explored. India is country with rich source of medicinal 
plants and wealthy knowledge of their usage for various 
infections  mentioned  in  the  many  texts  of  Ayurveda. 
Medicinal plants mentioned in ayurvedic texts need to be 
evaluated using modern in vitro antimicrobial assays.  
Although the introduction and successful development of 
this therapeutic class of antibacterial agents represents a 
significant medical achievement, this success has also led 
to  complacency  within  both  greater  society  and  the 
scientific community with regard to the development of 
bacterial  resistance.  In  spite  of  the  increased 
understanding  of  the  factors  contributing  to  the 
development  of  resistance  over  the  last  60  years,  the 
extent of this problem has not decreased with time and is 
currently  among  the  strongest  global  threats  to  the 
treatment of infectious disease. The degree to which this 
problem has progressed is demonstrated by the fact that 
resistance has developed against all available classes of 
antibiotics. Some important examples include penicillin-
resistant Streptococcus pneumoniae, vancomycin-resistant 
enterococci,  methicillin-resistant  Staphylococcus  aureus, 
multi-resistant  salmonellae,  and  multi-resistant 
Mycobacterium tuberculosis.  
Drugs acting on microbial agents have been mentioned in 
Ayurvedic  texts  as  Krimighna  Dravyas.  Evaluation  of 
medicinal  plants  as  an  alternative  to  the  antibiotics  has 
raised great interest in scientific community worldwide. 
Recently  several  reports  have  been  published  regarding 
screening  of  medicinal  plants  for  their  antibacterial 
activity against standard bacterial strains.  
Achyranthes aspera  L., has  been reported to have anti-
fertility
1,  anti-diabetic
2,  protyroidic
3,  anti-inflammatory 
and  anti-arthritic  activity
4,  immunomodulator
5, 
spermicidal
6  and  antiparastic
7  effects.  In  Ayurvedic 
textual references several dravyas have been mentioned as 
having  antimicrobial  activity  like,  Apamarga 
(Achyranthes  aspera)  (Raja  Nighantu;  Bhava  Prakash 
Nighantu). 
Reports  are  scanty  with  studies  on  screening  against 
pathogenic  bacteria  isolated  from  clinical  infections  of 
humans  and  animals  showing  resistance  to  commonly 
used antibacterial  agents.  In  view  of the  failures in the 
therapeutic  usage  of  antimicrobials  the  present  research 
was planned to evaluate efficacy of (Achyranthes aspera) 
apamarga,  a  plant  referred  in  Ayurvedic  texts  as 
‘krimighna’  on  clinically  isolated  multi-drug  resistant 
bacteria.  
 
MATERIALS AND METHODS 
Collection and identification of plant material 
Based  on  the  textual  references  in  Ayurveda  and  the 
available  recent  literatures,  Apamarga  (A.aspera)  was 
considered for antimicrobial activity in the present study. 
Their  authenticity  was  identified  and  confirmed  using 
morphological and anatomical features at Department of 
Botany,  College  of  Basic  Sciences,  Punjab  Agriculture 
University, Ludhiana, Punjab.  A voucher specimen was 
deposited  at  the  Herbarium  of  the  Babe  Ke  Ayurvedic 
College  and  Hospital,  Daudhar,  Moga,  Punjab 
(Herbarium Voucher No.BKACHD/DG/UP/2007/1).  
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Preliminary phytochemical analysis 
Preliminary  phytochemical  analysis  was  done  for 
qualitative  assessment  of  phytoconstituents  as  per  the 
standard  protocols  mentioned  previously
8.  Grounded 
dried  powder  was  subjected  to  tests  for  detection  of 
tannins,  alkaloids,  saponins,  cardiac  glycosides, 
anthraquinone  glycosides,  steroids:  (terpenoids  and 
flavonoids), resins and volatile oils. 
 
Preparation of crude drug extract from plant material 
Aqueous extraction of the drug was done by subjecting 20 
grams  of  air  dried  powder  to  soxhlet  extraction 
continuously for 12 hrs. The extract was air dried under 
mild heat  of 50
0 C till moisture completely evaporates. 
Ethanol,  methanol  and  chloroform  extractions  were 
accomplished  following  the  procedures  reported 
elsewhere  with  minor  modification  suiting  to  the 
laboratory  conditions.  For  each  extraction  the  ground 
powder was weighed 100 gms and immersed in ten times 
of 80% ethanol or methanol or chloroform and allowed 
for cold percolation on magnetic stirrer for 24 hrs. The 
extracts were first filtered through double layer of muslin 
cloth  and  then  with  Whatman  No.1  filter  paper.  The 
filtrate was air dried under low heat of 50
0 C and stored at 
-20
0 C till further use. 
 
 
 
 
Bacterial strains 
Standard bacterial and fungal strains were procured from 
Institute of Microbial Technology (IMTEC), Chandigarh, 
Department of Animal Biotechnology, Guru Anged Dev 
Veterinary  and  Animal  Sciences  University 
(GADVASU),  Ludhiana  and  Department  of 
Microbiology,  Christian  Medical  College,  Ludhiana. 
Bacterial  isolates  were  Klebsiella  spp.  Proteus  spp. 
Salmonella spp. Citrobacter spp. E.coli and Bacillus spp.  
 
Isolation and characterization of pathogenic bacteria 
from clinical samples 
Pathogenic  bacteria were isolated  from  clinical samples 
from  different  systems  like,  oral  cavity,  gastrointestinal 
and  respiratory  tract,  urinary  and  genital  infections. 
Pathogens were isolated from clinical samples collected at 
Department of Medical Microbiology, Christian Medical 
College (CMC), Ludhiana, Punjab. Isolated bacteria were 
identified  based  on  colony  morphology  and  staining 
characters  as  per  the  standard  protocols  mentioned  in 
Berge’s Manual of Systematic Bacteriology
9.  
 
Selection of multi-drug resistant bacteria  
Clinical  isolates  were  subjected  to  antibiotic  sensitivity 
test following standard disc diffusion  method
10.  Isolates 
having resistance to more than six of the tested antibiotic 
discs  were  considered  as  multi-drug  resistant  and  were 
selected for further analysis.   
 
 
Table 1: Biochemical parameters to identify the members of Enterobacteriaceae on selective/indicator media 
 
  Salmonella  Proteous  E.coli  Klebsiella  Citrobacter 
Lactose  -  -  +  +  +/- 
Sucrose  -  -  +/-  +  - 
Xylose  +  +  +  +  + 
H2S  +  +  -  -  - 
Lysine  +  -  +  +  - 
MacConkey agar  Pale colonies  Pale colonies  Bright pink  Pink  Pink 
Brilliant green agar  Red colonies  Red colonies  Yellow green  Yellow green  Green 
XLD agar  Red/black 
centre 
Yellow/black centre  Yellow  Yellow  Yellow 
 
Table 2: Yield of crude extract of Achyranthes aspera 
 
Solvent used for drug extract  Yield of crude extract (%) 
Aqueous 
Ethanol 
Methanol 
Chloroform 
7.9 
5.5 
4.8 
3.5 
 
Table 3: Antibacterial activity (percent inhibition) of crude plant extract of Achyranthes aspera against selected bacterial isolates 
 
Plant material  Bacillus  Citrobacter  E.coli  Klebsiella  Proteous  Salmonella 
Aqueous  50%  0%  10%  0%  0%  10% 
Ethanol  100%  0%  10%  0%  0%  10% 
Methanol  100%  75%  50%  10%  0%  25% 
Chloroform  100%  50%  50%  10%  0%  25% 
Bacteria control  0%  0%  0%  0%  0%  0% 
DMSO control  0%  0%  0%  0%  0%  0% 
 
Testing the antibacterial activity of plant extracts 
Antibacterial  activity  of  the  plant  extracts  was  done 
following  the  dilution  method  mentioned  elsewhere. 
Bacterial  strains  were  grown  to  exponential  phase  in 
Muller-Hinton broth at 37
0C for 18 hrs and adjusted to a 
final density of 10
8 CFU/ml by diluting fresh cultures and 
comparing  with  McFarland  density.  Antimicrobial 
activity of the different plant extracts was determined by a 
viable  colony  count.  Nine  hundred  microliter  of  a 
suspension  of  10
8  bacteria/ml  was  added  to  100  µl  of 
plant extract and incubated at 37
0C in shaker incubator for 
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each experiment in which isolates were diluted in DMSO. 
Following incubation serial tenfold dilution was made in 
Nutrient Broth  (10
-1 through  10
-4)  and  suspension  from 
the  last  dilution  was  spread  on  to  MHA  plates  and 
incubated at 37
0 C 24 hrs. Following incubation number 
of colonies in each plate was counted as colony forming 
unit  (CFU)  per  plate.  The  effectiveness  of  the  plant  at 
killing  bacterial  isolates  was  expressed  as  percentage 
inhibition  of  colony  growth  (i.e.  percentage  of  bacteria 
killed) compared to the control.   
 
RESULTS AND DISCUSSION  
Qualitative phytochemical analysis for tannins alkaloids, 
saponins,  cardiac  glycosides,  steroids:  terpenoids  and 
flavonoids were conducted to confirm the authenticity of 
the drugs collected for the present study. All the results 
were  in  accordance  with  the  previously  published 
standard observations. Characteristics of bacterial species 
isolated  in  the  study  showed  standard  biochemical 
reactions (Table 1). Yield of crude extract after extraction 
with various solvents are presented in Table 2. 
Aqueous extract of apamarga showed moderate inhibition 
on  Bacillus,  negligible  inhibition  on  E.coli  and  no 
inhibition  on  citrobacter,  klebsiella  and  proteus 
organisms.  Ethanol extract showed complete inhibition 
on  Bacillus,  negligible  inhibition  on  E.coli  and  no 
inhibition on citrobacter, klebsiella and proteus organism. 
Methanol extract showed complete inhibition on bacillus, 
significant inhibition on citrobacter,  moderate inhibition 
on  E.coli,  negligible  inhibition  on  klebsiella  and  no 
inhibition  on  proteus  organism.  Chloroform  extract 
showed  complete  inhibition  on  bacillus,  moderate 
inhibition  on  citrobacter  and  E.coli,  negligible  on 
klebsiella and no inhibition on Proteus organisms. Results 
are presented in Table 3.  
Current  research  on  natural  molecules  and  products 
primarily  focuses  on  plants  since  they  have  been 
extensively  described  in  Ayurvedic  literatures  and 
practiced routinely in Indian system of medicine. Ancient 
ayurvedic  textual  references  of  apamarga  are  on  its 
sahasraveerya,  krimighna,  rakshoghna,  rasayana, 
harshoghna,  vishaghna and rojopravarthaka.  It has been 
included in charaka samhimta as krimighna mahakashaya. 
In  the  present  study  ethanol,  methanol  and  chloroform 
extract  of  apamarga  showed  the  100%  inhibition  on 
Bacillus organism where as aqueous extract showed 50% 
inhibition which is in partial agreement with the previous 
observations that ethanol extract has antibacterial activity 
against  Bacillus  subtilis,  Staphylococcus  aureus, 
Pseudomonas  aeruginosa  and  Shigella  dysentriae
11.  In 
contrast to the present observations one of the previous 
report  could  detect  the  antibacterial  activity  of  crude 
methanol  extract  against  E.coli,  B.subtilis,  Yersinia 
enterocolitica and Candida albicans
12. Interestingly, none 
of the apamarga extracts showed any inhibitory activity 
on proteus bacteria while showed negligible inhibition on 
salmonella and klebsiella. This is the first report on effect 
of  apamarga  on  Salmonella,  proteus  and  klebsiella 
bacteria. In a similar study chloroform and methanol root 
and  shoot  extracts  of  A.  aspera  were  shown  to  have 
antibacterial  activity  against  Klebsiella  sp  and  ether 
extract  of  root  against  B.subtilis
13.  Results  suggest  that 
extract  has  significant  antibacterial  and  antifungal 
activity.  The  results  of  the  present  study  confirm  the 
explanations of ayurvedic claims as krimighna.  
Results  of  the  study  conclude  that  the  medicinal  plant 
Achyranthes aspera mentioned in Ayurvedic literature is 
having  huge  potential  for  use  as  antibacterial  agents 
especially  in  a  situation  where  available  drugs  are  not 
effective following development of  multidrug resistance 
in pathogens of clinical importance. However it should be 
noted  that  these  in  vitro  results  may  not  translate  into 
clinical  effectiveness.  Further,  studies  are  needed  to 
understand  the  phytoconstituents  responsible  for  the 
observed  antibacterial  activity  and  to  standardize  the 
dosage  and  administration  schedules  for  successful 
clinical applications in medical practice.  
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